A Redox Flow Battery Made From Iron Industry Waste

Researchers at the University of Southern California have found a way to make an effective and competitive redox flow battery out of the iron industry’s waste products.  Luckily for us, the results of the paper were posted on an open journal and we could take a look into the tech behind this battery.

As electric utilization, adoption of electric cars, and the use of renewable power continues to rise, engineers all over are searching for the perfect utility scale battery. We have all heard about Tesla’s 100MW lithium battery pack in South Australia. The system is a massive success and has already paid itself back. However, engineers all over were quick to point out that, until we have a breakthrough, Lithium cells are just not the right choice for a utility system in the long run. There has to be a better solution. Continue reading “A Redox Flow Battery Made From Iron Industry Waste”

Dr. Anthony Fauci, Infectious Disease Slayer

In the two months since the harsh realities of SARS-CoV-2 and COVID-19 have come into sharp focus, Americans have become increasingly familiar with a man who has been quietly serving the people since the days when Ronald Reagan was up for re-election. For many, Dr. Anthony Fauci is the national voice of reason in a sea of dubious information. He has arguably become the most trustworthy person the government has to offer in the face of this pandemic.

Officially, Dr. Fauci is the Director of the National Institute of Allergy and Infectious Diseases (NIAID), a position he was appointed to in 1984. He has worked under six presidents, advising them on every outbreak from the HIV/AIDS epidemic up through Zika and Ebola. Now, he is part of the White House’s coronavirus task force.

At 79 years old, he still works 18-hour days, sticking it to infectious diseases with one hand, and smoothing the feathers of the American people with the other. Dr. Fauci certainly feels like the right person at the right time. So how did he get to this point?

Continue reading “Dr. Anthony Fauci, Infectious Disease Slayer”

What Will You Do With An Extra 1.2 Gigahertz?

While our collective minds have been turned towards the global pandemic it’s refreshing to hear that in some quarters life has continued, and events that would have made the news in more normal times have continued to take place while they have been replaced in coverage by more urgent considerations.

In the last few weeks there has been a piece of routine American bureaucracy that flew under the radar but which will have a significant effect on global technology; the United States’ Federal Communication Commission first proposed, then ratified, the allocation of an extra 1200 MHz of spectrum in the 6 GHz band to ISM usage. This allocation process is likely to be repeated by other regions worldwide, freeing up another significant piece of spectrum for unlicensed usage.

In practice this means that there will be a whole new set of WiFi channels created, and we’ll all have a little more spectrum to play around with, so it’s worth examining in a little more detail. Continue reading “What Will You Do With An Extra 1.2 Gigahertz?”

EARN IT: Privacy, Encryption, And Policing In The Information Age

You may have heard about a new bill working its way through the US congress, the EARN IT act. That’s the “Eliminating Abusive and Rampant Neglect of Interactive Technologies Act of 2020”. (What does that mean? It means someone really wanted their initials to spell out “EARN IT”.)

EARN IT is a bipartisan bill that claims to be an effort to put a dent in child exploitation online. It’s also managed to catch the attention of the EFF, Schneier, and a variety of news outlets. The overwhelming opinion has been that EARN IT is a terrible idea, will make implementing end-to-end encryption impossible, and violates the First and Fourth Amendments. How does a bill intended to combat child pornography and sex trafficking end up on the EFF bad list? It’s complicated.

Continue reading “EARN IT: Privacy, Encryption, And Policing In The Information Age”

NASA’s Plan For Sustained Lunar Exploration

The Apollo program proved that humans could land on the Moon and do useful work, but due to logistical and technical limitations, individual missions were kept short. For the $28 billion ($283 billion adjusted) spent on the entire program, astronauts only clocked in around 16 days total on the lunar surface. For comparison, the International Space Station has cost an estimated $150 billion to build, and has remained continuously occupied since November 2000. Apollo was an incredible technical achievement, but not a particularly cost-effective way to explore our nearest celestial neighbor.

Leveraging lessons learned from the Apollo program, modern technology, and cooperation with international and commercial partners, NASA has recently published their plans to establish a sustained presence on the Moon within the next decade. The Artemis program, named for the twin sister of Apollo, won’t just be a series of one-off missions. Fully realized, it would consist not only of a permanent outpost where astronauts will work and live on the surface of the Moon for months at a time, but a space station in lunar orbit that provides logistical support and offers a proving ground for the deep-space technologies that will eventually be required for a human mission to Mars.

It’s an ambitious program on a short timeline, but NASA believes it reflects the incredible technological strides that have been made since humans last left the relative safety of low Earth orbit. Operating the International Space Station for 20 years has given the countries involved practical experience in assembling and maintaining a large orbital complex, and decades of robotic missions have honed the technology required for precision powered landings. By combining all of the knowledge gained since the end of Apollo, the Artemis program hopes to finally establish a continuous human presence on and around the Moon.

Continue reading “NASA’s Plan For Sustained Lunar Exploration”

Sticking Up For The Stick Shift

It seems that stick shift has become a sticking point, at least for American car buyers. Throughout 2019, less than 2% of all the cars sold in the US had a manual transmission. This sad picture includes everything from cute two-seater commuters to — surprisingly enough —  multi-million dollar super cars built for ultimate performance.

But aside from enthusiasts like myself, it seems no one cares too much about this shift away from manual transmissions. According to this video report by CNBC (embedded below), the fact that demand is in free-fall suggests that Americans on the whole just don’t enjoy driving stick anymore. And it stands to reason that as more and more people live their lives without learning to drive them, there would be a decline in the number of teachers and proponents. It’s a supply and demand problem starring the chicken and the egg.

But giving up the stick is one more example of giving up control over the vehicle. It’s not something everyone cares about, but those that do care a lot. Let’s grind through the ebb and flow of the manual transmission — more lovingly called the stick shift.

Continue reading “Sticking Up For The Stick Shift”

The Vaccine Factory Inside You: RNA Vaccine Basics

As the world pulls back from the acute phase of the COVID-19 pandemic, it enters what will be perhaps a more challenging time: managing the long-term presence of the SARS-CoV-2 virus that causes the disease. In the roughly two-century history of modern vaccination practices, we’ve gotten pretty good at finding ways to protect ourselves from infectious diseases, and there’s little doubt that we’ll do the same for SARS-CoV-2. But developing a vaccine against any virus or bacterium takes time, and in a pandemic situation, time is exactly what’s at a premium.

In an effort to create an effective vaccine against this latest viral threat, scientists and physicians around the world have been taking a different approach to inoculation. Rather than stimulating the immune system in the usual way with a weakened sample of the virus, they’re trying to use the genetic material of the virus to stimulate an immune response. These RNA vaccines are a novel approach to a novel infection, and understanding how they work will be key to deciding whether they’ll be the right way to attack this pandemic.

Continue reading “The Vaccine Factory Inside You: RNA Vaccine Basics”